West Pharmaceutical Services (WST) - Stock & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9553061055
West Pharmaceutical Services Inc., listed on the New York Stock Exchange as WST, is a company that creates and sells specialized containment and delivery systems for injectable medications and healthcare items across various regions globally. These regions include the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
The company operates in two distinct segments known as Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment focuses on producing stoppers, seals, syringe components, cartridge components, films, coatings, washing services, and vision inspection services, all aimed at enhancing the packaging and administration of injectable drugs. They also offer drug containment solutions like Crystal Zenith and self-injection devices, alongside a range of integrated services and solutions for pharmaceutical companies.
On the other hand, the Contract-Manufactured Products segment deals with the design and manufacture of various devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company's clientele includes pharmaceutical, diagnostic, and medical device companies.
Founded in 1923 and headquartered in Exton, Pennsylvania, West Pharmaceutical Services operates a comprehensive distribution network that includes a dedicated sales force, distribution network, contract sales agents, and regional distributors. For more information, you can visit their official website at https://www.westpharma.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
WST Stock Overview
Market Cap in USD | 28,533m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC SubIndustry | Health Care Supplies |
TER | 0.00% |
IPO / Inception | 1978-01-13 |
WST Stock Ratings
Growth 5y | 6.37 |
Fundamental | 63.1 |
Dividend | 6.32 |
Rel. Performance vs Sector | -0.40 |
Analysts | 4.10/5 |
Fair Price Momentum | 357.31 USD |
Fair Price DCF | 158.35 USD |
WST Dividends
Yield 12m | 0.22% |
Yield on Cost 5y | 0.65% |
Dividends CAGR 5y | 4.77% |
Payout Consistency | 99.9% |
WST Growth Ratios
Growth 12m | -0.01% |
Growth Correlation 12m | 9% |
Growth Correlation 3m | -1% |
CAGR 5y | 24.37% |
Sharpe Ratio 12m | -0.17 |
Alpha vs SP500 12m | -22.75 |
Beta vs SP500 5y weekly | 0.93 |
ValueRay RSI | 8.96 |
Volatility GJR Garch 1y | 28.51% |
Price / SMA 50 | -4.28% |
Price / SMA 200 | -2.8% |
Current Volume | 599.9k |
Average Volume 20d | 408.6k |
External Links for WST Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 27, 2024, the stock is trading at USD 360.43 with a total of 599,944 shares traded.
Over the past week, the price has changed by -3.07%, over one month by -7.11%, over three months by -0.15% and over the past year by +1.12%.
According to ValueRays Forecast Model, WST West Pharmaceutical Services will be worth about 397.9 in April 2025. The stock is currently trading at 360.43. This means that the stock has a potential upside of +10.4%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 400.4 | 11.1 |
Analysts Target Price | 400.7 | 11.2 |
ValueRay Target Price | 397.9 | 10.4 |